(Total Views: 256)
Posted On: 11/09/2022 2:45:50 PM
Post# of 35
$RPRX News Article - Royalty Pharma Agrees to Acquire Royalty Interest in Olpasiran From Arrowhead for $250 million and Future Milestones https://marketwirenews.com/news-releases/roya...21878.html
(0)
(0)
My Twitter: WhyteStocks
